REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sofiva Genomics Co., Ltd. (慧智基因股份有限公司) (Taiwan, China)

Main Activities: Ambulatory Health Care Services
Full name: Sofiva Genomics Co., Ltd. Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Sofiva Genomics Co., Ltd. is mainly engaged in biochemical research and development. The company's business includes genetic testing of maternal fetuses, genetic testing of rare diseases, etc. Sofiva Genomics Co., Ltd.was established in 2010 and located in New Taipei City.

Headquarters
4F.-2, No. 66-1, Sec. 1, Chongqing S. Rd Zhongzheng Dist
Taipei City; Taipei City;

Contact Details: Purchase the Sofiva Genomics Co., Ltd. (慧智基因股份有限公司) report to view the information.

Website: http://www.sofivagenomics.com.tw

Basic Information
Total Employees:
Purchase the Sofiva Genomics Co., Ltd. (慧智基因股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Sofiva Genomics Co., Ltd. (慧智基因股份有限公司) report to view the information.
Financial Auditors:
Purchase the Sofiva Genomics Co., Ltd. (慧智基因股份有限公司) report to view the information.
Incorporation Date:
June 15, 2012
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
11.37%
Purchase this report to view the information.
2.18%
Purchase this report to view the information.
0.52%
Purchase this report to view the information.
0.13%
Purchase this report to view the information.
Subsidiaries
群智基因股份有限公司
100%
Sofiva Genomics Bangkok Co., Ltd. (Thailand)
90%
Company Performance
Financial values in the chart are available after Sofiva Genomics Co., Ltd. (慧智基因股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-17.1%▼
Total operating revenue
-16.01%▼
Operating profit (EBIT)
N/A
EBITDA
-49.9%▼
Net Profit (Loss) for the Period
N/A
Total Assets
-6.31%▼
Total Equity
-2.48%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt/Equity
-2.69%▼
Quick Ratio
0.13%▲
Cash Ratio
-0.07%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo